June 4, 2008
 

Ipca labs to manufacture drug for US market - Business Standard


Ipca labs to manufacture drug for US market - Business Standard
Ipca Laboratories has received approval from US Food and Drugs Administration to manufacture Propranolol Hydrochloride Tablets USP 10 mg, 20 mg, 40 mg, 60 mg and 80 mg for the US market. The company informed the Bombay Stock Exchange that it will
Source: www.business-standard.com

FDA urged to ban 8 dyes used in food - Boston Globe
WASHINGTON - The United States should ban eight food dyes, used in products including General Mills Inc.'s Lucky Charms cereal, because of links to hyperactivity and other disruptive behavior in children, a health advocacy group said. The Center for
Source: www.boston.com

Antiobesity Drug Linked to Deaths - Wall Street Journal
LONDON -- Sanofi-Aventis SA's antiobesity pill Acomplia has been linked to the deaths of five patients, according to findings by the United Kingdom's drug regulator, raising concerns about the controversial treatment and another similar medicine. One
Source: online.wsj.com

Call to Ban Certain Food Colors Save Email Print - WHSV
A consumer group is asking the Food and Drug Administration to ban the use of eight artificial food colorings. The Center for Science in the Public Interest claims that the dyes can lead to hyperactivity and behavior problems in children. The center
Source: www.whsv.com

India's Ipca gets U.S. FDA approval for propranolol hydrochloride - Forbes
MUMBAI (Thomson Financial) - Ipca Laboratories Ltd. said it received approval from the U.S. Food and Drug Administration to make propranolol hydrochloride tablets, used in the treatment of high blood pressure and angina pectoris. The tablet has
Source: www.forbes.com

Subscribe to Posts [Atom]